The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Abstract
Toll-like receptors (TLRs) play a key role in the innate immune response. The aim of this study was to examine the expression of TLR2 and TLR4 in chronic hepatitis B (CHB). The TLR2 and TLR4 expression on hepatocytes and Kupffer cells from fresh liver biopsies was measured from 21 patients with untreated hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB. Parallel studies were also undertaken on monocytes from their peripheral blood. Expression of TLR2 on hepatocytes, Kupffer cells, and peripheral monocytes was significantly reduced in patients with HBeAg-positive CHB in comparison with HBeAg-negative CHB and controls, whereas it was significantly increased in HBeAg-negative CHB compared with controls. The level of TLR4 expression did not differ significantly between the groups. These results were confirmed in vitro using hepatic cell lines transduced with recombinant HBV baculovirus expressing wild-type HBV (HBeAg-positive), precore stop codon (G1896A) mutant HBV (HBeAg-negative). The functional relevance of these findings was established by the demonstration of significantly reduced cytokine production (TNF-α) and phospho-p38 kinase expression in the presence of the HBeAg. In the absence of HBeAg, HBV replication was associated with up-regulation of the TLR2 pathway leading to increased TNF-α production. Conclusion : This study demonstrates a potentially important interaction between HBeAg, HBV, and the innate immune response. (Hepatology 2007;45:102–110.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Toll-Like Receptor Signaling Pathways
Barton, G. M., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1085536 · Cited by 1,265
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria
Zhang, D., Zhang, G., Hayden, M. S., Greenblatt, M. B., Bussey, C., Flavell, R. A., & Ghosh, S. (2004) · Science · doi:10.1126/science.1094351 · Cited by 1,004
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
Self-citationGlobal control of hepatitis B virus infection
Kao, J.-H., & Chen, D.-S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00315-8 · Cited by 805
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
How we detect microbes and respond to them: the Toll-like receptors and their transducers
Beutler, B., Hoebe, K., Du, X., & Ulevitch, R. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0203082 · Cited by 591
Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., & Schneider-Schaulies, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8729-8736.2002 · Cited by 509
Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
Haynes, L. M., Moore, D. D., Kurt-Jones, E. A., Finberg, R. W., Anderson, L. J., & Tripp, R. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10730-10737.2001 · Cited by 496
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., & Seya, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00380-7 · Cited by 451
Redecke, V., Häcker, H., Datta, S. K., Fermin, A., Pitha, P. M., Broide, D. H., & Raz, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2739 · Cited by 448
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 442
Murine retroviruses activate B cells via interaction with toll-like receptor 4
Rassa, J. C., Meyers, J. L., Zhang, Y., Kudaravalli, R., & Ross, S. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042355399 · Cited by 399
Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus Infection
Milich, D., & Liang, J. T. (2003) · Hepatology · doi:10.1053/jhep.2003.50453 · Cited by 393
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
Lien, E., & Ingalls, R. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00001 · Cited by 273
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus
Yuh, C. H., Chang, Y. L., & Ting, L. P. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4073-4084.1992 · Cited by 193
Toll‐Like Receptor 3: A Link between Toll‐Like Receptor, Interferon and Viruses
Matsumoto, M., Funami, K., Oshiumi, H., & Seya, T. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03500.x · Cited by 189
Role of Toll‐like receptors in costimulating cytotoxic T cell responses
Schwarz, K., Storni, T., Manolova, V., Didierlaurent, A. M., Sirard, J., Röthlisberger, P., & Bachmann, M. F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323919 · Cited by 171
Riordan, S. M., Skinner, N., Nagree, A., McCallum, H., McIver, C. J., Kurtovic, J., Hamilton, J. A., Bengmark, S., Williams, R., & Visvanathan, K. (2003) · Hepatology · doi:10.1053/jhep.2003.50180 · Cited by 167
Self-citationBiermer, M., Puro, R., & Schneider, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4033-4042.2003 · Cited by 166
Delaney, W. E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G., & Locarnini, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3057-3060.2002 · Cited by 158
Self-citationDelaney, W. E., & Isom, H. C. (1998) · Hepatology · doi:10.1002/hep.510280432 · Cited by 144
Bouchard, M. J., Puro, R. J., Wang, L., & Schneider, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7713-7719.2003 · Cited by 131
Chen, R. Y. M., Edwards, R., Shaw, T., Colledge, D., Delaney, W. E., Isom, H. C., Bowden, S., Desmond, P. V., & LOCARNINI, S. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50012 · Cited by 121
Self-citationDelaney, W. E., Edwards, R., Colledge, D., Shaw, T., Torresi, J., Miller, T. G., Isom, H. C., Bock, C. –., Manns, M. P., Trautwein, C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1705-1713.2001 · Cited by 93
Self-citationZhang, W., Yue, B., Wang, G., & Lu, S.-L. (2002) · PubMed · Cited by 56
Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection
Hadziyannis, S. J., & Vassilopoulos, D. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00173-5 · Cited by 50
Locarnini, S., Shaw, T., Dean, J., Colledge, D., Thompson, A. J. V., Li, K., Lemon, S. M., Lau, G. K. K., & Beard, M. R. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.10.002 · Cited by 26
Self-citation
Cited by
Yuen, M.-F., Chen, D.-S., Dusheiko, G. M., Janssen, H. L. A., Lau, D. T. Y., Locarnini, S. A., Peters, M. G., & Lai, C.-L. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 814
Self-citationControl of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552
“Kupffer cells and dendritic cells play a major role in mediating both innate and adaptive immune responses and the molecular mechanisms by which the innate and adaptive immune response can affect viral replication are only starting to emerge [53–56].”
BackgroundTherapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Bertoletti, A., & Ferrari, C. (2012) · Gut · doi:10.1136/gutjnl-2011-301073 · Cited by 477
Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01492.x · Cited by 366
Metadata
- Authors
- Visvanathan, K., Skinner, N. A., Thompson, A. J. V., Riordan, S. M., Sozzi, V., Edwards, R., Rodgers, S., Kurtovic, J., Chang, J., Lewin, S., Desmond, P., & Locarnini, S.
- Venue
- Hepatology
- Published
- 2007-01
- Volume
- 45
- Issue
- 1
- Pages
- 102-110
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1974551062
- Cited by
- 339
- References
- 35
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.